Ulrich Lichtenthaler, a management professor at the University of Mannheim who has retracted three papers for statistical irregularities, has another retraction for his CV, this one in the Strategic Management Journal. There’s no notice yet; all that appears for the January 2012 paper is this:
The British Journal of Clinical Pharmacology has issued an “expression of concern” for a 2003 review article, based on a previous lecture, with close echoes to a paper that had appeared in one of The Lancet titles. Here’s the notice for the article, by Peter Winstanley, dean of the Warwick Medical School in the United … Continue reading Pharmacology journal expresses concern over “similar, but updated” review
Last December, we reported on a Journal of Immunology paper that was retracted after a Cardiff University investigation found the senior author had inappropriately manipulated images. The inquiry found that there had been “no intention to mislead and subsequent repeats of the original experiments have shown that the paper’s conclusions remain sound,” the university told … Continue reading Cardiff University looking into allegations of misconduct by group headed by its dean of medicine
As Retraction Watch readers know, we’re big fans of transparency. Today, for example, The Scientist published an opinion piece we wrote calling for a Transparency Index for journals. So perhaps it’s no surprise that we’re also big fans of open peer review, in which all of a papers’ reviews are made available to readers once … Continue reading Transparency in action: EMBO Journal detects manipulated images, then has them corrected before publishing
Expert Opinion on Pharmacotherapy has retracted a 2011 paper for plagiarism by two authors, one of whom, V. Craig Jordan, is a leading researcher on the class of drugs known as selective estrogen receptor modulators, or SERMs, and is credited with discovering the anti-tumor properties of the breast cancer drug tamoxifen. Jordan, who is scientific … Continue reading Plagiarism topples paper co-authored by top tamoxifen scientist
Duplication — sometimes referred to “self-plagiarism,” with a lack of precision — is a frequent cause of retractions. Usually, it’s of text that authors have used elsewhere. But what about data? In our new LabTimes column, we describe a hypothetical situation:
Yesterday, we reported on a retraction in the Journal of Neuroscience for “substantial data misrepresentation.” When we posted, the authors’ institution, Memorial University in Newfoundland, Canada, had not been able to respond to our questions yet, because of the long Canada Day weekend. This morning, they sent us the following statement, which describes the errors … Continue reading Canada’s Memorial U says “substantial data misrepresentation” described by retraction notice was unintentional
Back in April, a group of French and Tunisian researchers published a paper in Biomaterials which came to the astonishing conclusion that buckyballs (carbon tetrachloride) coated in olive oil could dramatically extend the lives of lab rodents. That news was picked up by Derek Lowe’s In the Pipeline blog, on which he expressed some bemusement … Continue reading Controversial paper on life-extending buckyballs corrected after blog readers note problems
A group of researchers at the drug company ChemoCentryx is withdrawing a 2012 paper in the Journal of Pharmacology and Experimental Therapeutics over failure to appropriately identify the molecule they describe in the article. The withdrawal notice tells the story:
The European Journal of Cardiothoracic Surgery has retracted a 2007 article by Chinese researchers after the senior author decided he liked the data so nice he’d publish them twice. And he appears to have done so without the knowledge of the corresponding author. Here’s the notice for the paper, titled “Open-heart surgery in patients with … Continue reading Tell-tale hearts: Cardiology journals retract redundant articles